Correspondence: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies

Detalles Bibliográficos
Autores principales: Petereit, Hela-Felicitas, Tumani, Hayrettin, Zettl, Uwe K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182197/
https://www.ncbi.nlm.nih.gov/pubmed/34158837
http://dx.doi.org/10.1177/17562864211022581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182197/
https://www.ncbi.nlm.nih.gov/pubmed/34158837
http://dx.doi.org/10.1177/17562864211022581

Ejemplares similares